Digest Network Come funziona
Network
/
Società
AC
Non verificato

ACADIA Pharmaceuticals Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

60 comunicati stampa

Guarda tutti i comunicati
20/11/2025
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
28/10/2025
Biotecnologia
Farmaceutica
Salute
Eventi
Web e Social Network
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
15/10/2025
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
02/10/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Eventi
Industria
Acadia Pharmaceuticals Presents Clinical Data from Across Multiple Therapeutic Programs at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
24/09/2025
Industria
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
12/09/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Industria
Real World Data from LOTUS Study Evaluating Long-term Efficacy and Tolerability Outcomes of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Developmental Medicine and Child Neurology
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
08/09/2025
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Finanza
Mercato azionario
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
26/08/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Eventi
Web e Social Network
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0
25/08/2025
Psichiatria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Acadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0